> top > docs > PMC:1283364 > spans > 61306-61502 > annotations

PMC:1283364 / 61306-61502 JSONTXT

Annnotations TAB JSON ListView MergeView

craft-sa-dev

Id Subject Object Predicate Lexical cue
T12923 0-196 sentence denotes It is possible that a combination of therapies to limit Aβ production, increase Aβ degradation, and enhance phagocytosis of deposited amyloid may be required to reverse damage associated with AD.
T12924 1-3 PRP denotes It
T12925 4-6 VBZ denotes is
T12926 7-15 JJ denotes possible
T12927 16-20 IN denotes that
T12928 150-158 VBN denotes required
T12929 21-22 DT denotes a
T12930 23-34 NN denotes combination
T12931 35-37 IN denotes of
T12932 38-47 NNS denotes therapies
T12933 48-50 TO denotes to
T12934 51-56 VB denotes limit
T12935 57-59 NN denotes Aβ
T12936 60-70 NN denotes production
T12937 70-72 , denotes ,
T12938 72-80 VB denotes increase
T12939 81-83 NN denotes Aβ
T12940 84-95 NN denotes degradation
T12941 95-97 , denotes ,
T12942 97-100 CC denotes and
T12943 101-108 VBP denotes enhance
T12944 109-121 NN denotes phagocytosis
T12945 122-124 IN denotes of
T12946 125-134 VBN denotes deposited
T12947 135-142 NN denotes amyloid
T12948 143-146 MD denotes may
T12949 147-149 VB denotes be
T12950 159-161 TO denotes to
T12951 162-169 VB denotes reverse
T12952 170-176 NN denotes damage
T12953 177-187 VBN denotes associated
T12954 188-192 IN denotes with
T12955 193-195 NN denotes AD
T12956 195-196 . denotes .
R9184 T12934 T12932 advcl limit,therapies
R9189 T12935 T12936 compound Aβ,production
R9193 T12936 T12934 dobj production,limit
R9196 T12937 T12934 punct ", ",limit
R9200 T12938 T12934 conj increase,limit
R9204 T12939 T12940 compound Aβ,degradation
R9207 T12940 T12938 dobj degradation,increase
R9209 T12941 T12938 punct ", ",increase
R9216 T12942 T12938 cc and,increase
R9219 T12943 T12938 conj enhance,increase
R9223 T12944 T12943 dobj phagocytosis,enhance
R9226 T12945 T12944 prep of,phagocytosis
R9230 T12946 T12947 amod deposited,amyloid
R9233 T12947 T12945 pobj amyloid,of
R9235 T12948 T12928 aux may,required
R9236 T12924 T12925 nsubj It,is
R9237 T12926 T12925 acomp possible,is
R9238 T12949 T12928 auxpass be,required
R9239 T12927 T12928 mark that,required
R9240 T12928 T12925 ccomp required,is
R9241 T12929 T12930 det a,combination
R9242 T12950 T12951 aux to,reverse
R9243 T12930 T12928 nsubjpass combination,required
R9244 T12931 T12930 prep of,combination
R9245 T12951 T12928 advcl reverse,required
R9246 T12932 T12931 pobj therapies,of
R9247 T12933 T12934 aux to,limit
R9248 T12952 T12951 dobj damage,reverse
R9249 T12953 T12952 acl associated,damage
R9250 T12954 T12953 prep with,associated
R9252 T12955 T12954 pobj AD,with
R9253 T12956 T12925 punct .,is

craft-ca-core-ex-dev

Below, discontinuous spans are shown in the chain model. You can change it to the bag model.

Id Subject Object Predicate Lexical cue
T10525 57-59 CHEBI_PR_EXT:amyloid_beta denotes Aβ
T10526 57-70 GO:0034205 denotes Aβ production
T10527 81-83 CHEBI_PR_EXT:amyloid_beta denotes Aβ
T10528 109-121 GO:0006909 denotes phagocytosis
T10529 135-142 CHEBI:60425 denotes amyloid

craft-ca-core-dev

Below, discontinuous spans are shown in the chain model. You can change it to the bag model.

Id Subject Object Predicate Lexical cue
T10186 57-70 GO:0034205 denotes Aβ production
T10187 109-121 GO:0006909 denotes phagocytosis
T10188 135-142 CHEBI:60425 denotes amyloid